Distal iodine density and effective atomic number abnormalities associated with pulmonary arterial involvement in lung cancer: a dual-layer spectral CT study

Objectives To investigate whether distal lung parenchymal abnormalities detected on dual-layer spectral CT (DLCT), quantified by iodine density (ID) and effective atomic number (Zeff), are associated with pulmonary arterial involvement in patients with lung cancer. Materials and methods This retrospective study included 61 patients with pathologically confirmed lung cancer who underwent contrast-enhanced DLCT between June 2024 and September 2025. Regions of interest (ROIs) were placed in the distal and contralateral lung parenchyma. Conventional CT attenuation, ID and Zeff were measured on arterial-phase spectral images. Pulmonary arterial involvement was determined by predefined CT criteria, including segmental luminal narrowing or truncation of the pulmonary artery. Associations of distal spectral CT parameters with tumor size, tumor location and pulmonary arterial involvement were evaluated using subgroup analyses and multivariable linear regression. Results Interobserver agreement was excellent (intraclass correlation coefficient, ICC range, 0.87–0.99). ID and Zeff were significantly lower in the distal than in the contralateral lung parenchyma (both p < 0.01), whereas conventional CT attenuation showed no significant difference (p > 0.05). Greater relative differences in ID and Zeff were observed in tumors ≥30 mm, central tumors, and cases with pulmonary arterial involvement (all p < 0.01). After adjustment for tumor size and location, pulmonary arterial involvement remained significantly associated with both spectral parameters. Conclusion Spectral CT may provide complementary quantitative information on distal lung changes associated with pulmonary arterial abnormalities beyond conventional CT assessment.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-18
DOI
https://doi.org/10.3389/fonc.2026.1964025
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Distal iodine density and effective atomic number abnormalities associated with pulmonary arterial involvement in lung cancer: a dual-layer spectral CT study

武维屏, Shan Yang, XiaoKun Zhang, Yujie Wang et al.
Frontiers in Oncology
Lung Cancer Diagnosis and Treatment
article

Distal iodine density and effective atomic number abnormalities associated with pulmonary arterial involvement in lung cancer: a dual-layer spectral CT study

武维屏, Shan Yang, XiaoKun Zhang, Yujie Wang, Zhu HaiFeng, Bin Liu, Jing Wen, Jun Qin, Weifang Liu
article en

Abstract

Objectives To investigate whether distal lung parenchymal abnormalities detected on dual-layer spectral CT (DLCT), quantified by iodine density (ID) and effective atomic number (Zeff), are associated with pulmonary arterial involvement in patients with lung cancer. Materials and methods This retrospective study included 61 patients with pathologically confirmed lung cancer who underwent contrast-enhanced DLCT between June 2024 and September 2025. Regions of interest (ROIs) were placed in the distal and contralateral lung parenchyma. Conventional CT attenuation, ID and Zeff were measured on arterial-phase spectral images. Pulmonary arterial involvement was determined by predefined CT criteria, including segmental luminal narrowing or truncation of the pulmonary artery. Associations of distal spectral CT parameters with tumor size, tumor location and pulmonary arterial involvement were evaluated using subgroup analyses and multivariable linear regression. Results Interobserver agreement was excellent (intraclass correlation coefficient, ICC range, 0.87–0.99). ID and Zeff were significantly lower in the distal than in the contralateral lung parenchyma (both p < 0.01), whereas conventional CT attenuation showed no significant difference (p > 0.05). Greater relative differences in ID and Zeff were observed in tumors ≥30 mm, central tumors, and cases with pulmonary arterial involvement (all p < 0.01). After adjustment for tumor size and location, pulmonary arterial involvement remained significantly associated with both spectral parameters. Conclusion Spectral CT may provide complementary quantitative information on distal lung changes associated with pulmonary arterial abnormalities beyond conventional CT assessment.

Frontiers in OncologyVol. 16
Aviation General Hospital (CN)
Good health and well-being
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon